Regulatory News - Europes Headlines

Key data on U.S. J&J, Moderna COVID-19 boosters 'weeks away,' Fauci says

Data needed to determine the advisability of booster shots of the Moderna Inc and Johnson & Johnson COVID-19 vaccines is just weeks away, President Joe Biden's chief medical adviser said on Sunday, as officials signaled they expected boosters would be recommended for a broad swath of Americans.

EXPLAINER-The case for, and against, COVID-19 vaccine boosters

The U.S. government aims to begin offering COVID-19 vaccine booster shots widely next week to Americans age 16 and up. A panel of outside advisers to the Food and Drug Administration voted against such broad coverage on Friday but backed a shot for people 65 and older, which the agency may or may not follow.

Politics Video

Politics News